Roche Holding AG acquires 89bio Inc. for $3.5B, adding promising MASH and hypertriglyceridemia treatments. Click for more on ...

A meds-to-beds program implemented at New York City-based Montefiore Health System improved low-density lipoprotein cholesterol in patients undergoing coronary or peripheral artery revascularization, ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for lisocabtagene maraleucel (liso-cel) for adults with relapsed or ...

It can be hard to keep track of all the information you get about your cancer diagnosis and treatment. But keeping everything ...

CRISPR — short for clustered regularly interspaced short palindromic repeats — is a method of genetic editing that uses RNA ...